Cite
HARVARD Citation
Williet, N. et al. (2019). Folfirinox versus gemcitabine/nab-paclitaxel as first-line therapy in patients with metastatic pancreatic cancer: a comparative propensity score study. Therapeutic advances in gastroenterology. p. . [Online].